Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform pr...
Main Authors: | A. S. Tereshchenko, T. M. Uskach, N. V. Kondratova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-07-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4452 |
Similar Items
-
Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction
by: A. V. Khripun, et al.
Published: (2019-05-01) -
Pharmacoinvasive Strategy in Acute STEMI
by: Isman Firdaus
Published: (2013-06-01) -
CURRENT REPERFUSION THERAPY POSSIBILITIES IN MYOCARDIAL INFARCTION AND ISCHEMIC STROKE
by: E. V. Konstantinova, et al.
Published: (2015-05-01) -
Relationship Between Arterial Access and Outcomes in ST‐Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
by: Jay Shavadia, et al.
Published: (2016-06-01) -
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil
by: Pedro Ivo De Marqui Moraes, et al.
Published: (2023-06-01)